| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |